IRIS
MORSIA, Erika
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.905
AS - Asia 1.303
EU - Europa 978
SA - Sud America 366
AF - Africa 104
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.659
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.836
SG - Singapore 351
IT - Italia 343
VN - Vietnam 334
BR - Brasile 274
CN - Cina 244
RU - Federazione Russa 213
HK - Hong Kong 134
FR - Francia 84
DE - Germania 70
BD - Bangladesh 63
IE - Irlanda 51
IN - India 48
CI - Costa d'Avorio 46
GB - Regno Unito 43
AR - Argentina 38
FI - Finlandia 38
NL - Olanda 37
MX - Messico 31
CA - Canada 24
SE - Svezia 21
AT - Austria 20
ID - Indonesia 17
MA - Marocco 17
JP - Giappone 16
PL - Polonia 16
ES - Italia 14
VE - Venezuela 13
EC - Ecuador 12
IQ - Iraq 12
ZA - Sudafrica 12
TR - Turchia 11
CO - Colombia 9
PE - Perù 8
TH - Thailandia 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 6
PH - Filippine 6
PK - Pakistan 6
PY - Paraguay 6
CL - Cile 5
CR - Costa Rica 5
KR - Corea 5
SN - Senegal 5
TN - Tunisia 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
EG - Egitto 4
JO - Giordania 4
KZ - Kazakistan 4
LT - Lituania 4
MY - Malesia 4
NP - Nepal 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
SA - Arabia Saudita 3
AL - Albania 2
BW - Botswana 2
ET - Etiopia 2
GR - Grecia 2
JM - Giamaica 2
KE - Kenya 2
MT - Malta 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
TZ - Tanzania 2
UA - Ucraina 2
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
TG - Togo 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 4.659
Salva come PNG Salva come JPEG
Città #
Ashburn 480
Singapore 213
Dallas 198
San Jose 168
Hong Kong 128
Ho Chi Minh City 116
Los Angeles 94
Boardman 91
Hanoi 79
Beijing 57
Dublin 51
Hefei 50
New York 49
Abidjan 46
Council Bluffs 45
Lauterbourg 45
Ancona 42
Munich 40
Chandler 38
Chicago 36
Buffalo 35
Milan 34
Moscow 34
The Dalles 29
Helsinki 25
São Paulo 24
Denver 23
Orem 22
Rome 21
Turin 19
Santa Clara 18
Brooklyn 17
Washington 17
Salt Lake City 16
Chennai 15
Frankfurt am Main 15
Haiphong 15
Amsterdam 13
Turku 13
Mexico City 12
Da Nang 11
London 11
Tokyo 11
Warsaw 11
Guangzhou 10
Seattle 10
Bari 9
San Francisco 9
Stockholm 9
Boston 8
Houston 8
Montreal 8
Nuremberg 8
Tashkent 8
Manchester 7
Mumbai 7
Naples 7
Rio de Janeiro 7
Shanghai 7
Atlanta 6
Caracas 6
Elk Grove Village 6
Hải Dương 6
Johannesburg 6
Ninh Bình 6
Tampa 6
Vienna 6
Baghdad 5
Bangkok 5
Can Tho 5
Columbus 5
Dakar 5
Falconara Marittima 5
Lima 5
Medellín 5
Miami 5
New Delhi 5
North Charleston 5
Osimo 5
Paris 5
Phoenix 5
Wuhan 5
Andria 4
Baku 4
Biên Hòa 4
Bologna 4
Brasília 4
Campinas 4
Cardiff 4
Charlotte 4
City of London 4
Clifton 4
Fortaleza 4
Guarulhos 4
Guayaquil 4
Huế 4
Lawrence 4
Miano 4
Perugia 4
Poplar 4
Totale 2.844
Salva come PNG Salva come JPEG
Nome #
Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region 162
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 156
Shaping the Future of Myeloproliferative Neoplasm Therapy: Immune-Based Strategies and Targeted Innovations 153
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 150
A rare case of aCML associated with CNS involvement and with aggressive clinical course 137
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas 136
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications 130
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 123
NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES 122
Bone Marrow Adipose Tissue 122
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints 116
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 114
Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry: An Italian Center Experience 109
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis 108
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report 105
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 103
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients 102
Clinico-Pathological, Cytogenetic and Molecular Similarities and Differences between Primary and Secondary Cutaneous Lymphomas 102
Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases 102
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment 101
AL amyloidosis: an overview on diagnosis, staging system, and treatment 99
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 98
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study 97
Transfusion dependence is a risk factor for severe infections in myelodysplastic syndromes 96
Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights 94
Pediatric primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: A retrospective analysis and review of the literature 94
Is There a Correlation Between Immune Thrombocytopenia and Immunoglobulin G4-Related Disease? 94
Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project 91
Myeloproliferative Neoplasms with Monocytosis 87
P1045: IS JAK2V617F BUT NOT CALR AS DRIVER MUTATION ENOUGH BY ITSELF IN THE PATHOGENESIS OF UNUSUAL TYPE VENOUS THROMBOSIS IN MPN PATIENTS? 84
Expression of Paraoxonase-2 in Different Stages of Cutaneous T Cell Lymphoma: Is It a Potential Biomarker for Aggressiveness? 82
The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management 81
Epidemiology and Risk Factors for Infections in Myelodysplastic Syndromes 78
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI) 77
Multidisciplinary and personalized approach to the management of mycosis fungoides with chlormethine gel: a collection of clinical experiences 72
Impact of calreticulin mutations on treatment and survival outcomes in myelofibrosis during ruxolitinib therapy 69
Clinical outcomes of ruxolitinib treatment in 595 intermediate-1 risk patients with myelofibrosis: The RUX-MF Real-World Study 69
Myelofibrosis: challenges for preclinical models and emerging therapeutic targets 68
Sequential Bispecific Antibodies in Functional and Clinical High Risk Multiple Myeloma, Manifesting with Extramedullary Disease at Relapse: A Case Report 67
Long-Term Efficacy of Psoralen Plus Ultraviolet a Irradiation and Low-Dose Interferon-Alpha Therapy According to Conventional and Emerging Clinical Endopoints of Early Stage Cutaneous T Cell Lymphoma 66
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma Patients 62
Mutations and thrombosis in essential thrombocythemia 62
WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): A contemporary series from the Mayo Clinic 61
Disease Phenotype Significantly Influences the Outcome After Discontinuation of Ruxolitinib in Chronic Phase Myelofibrosis 60
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea 60
Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patients 59
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome 59
IDH2 Inhibitor Therapy in Relapsed and Refractory Acute Myeloid Leukemia: A Single Institution Experience 56
Paraoxonase-2 in cutaneous T cell lymphomas. 53
Erythroid-stimulating agents in VEXAS syndrome: A retrospective study from an Italian multicentre cohort 50
Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study 48
Ruxolitinib after fedratinib failure in patients with myelofibrosis: A real-world case series 45
The Strange Case of Functional High-Risk Multiple Myeloma Patients: Is It Possible to Identify Them in Clinical Practice? 14
Genetic insights into myeloproliferative neoplasms and unusual sites thrombosis 8
Totale 4.813
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202230 7 1 0 0 0 1 3 2 0 3 6 7
2022/2023157 6 9 7 12 7 9 1 9 26 0 60 11
2023/2024378 37 12 38 44 57 54 11 13 3 28 15 66
2024/20251.011 66 66 38 19 31 53 96 24 171 55 193 199
2025/20263.237 213 252 295 384 311 253 525 260 246 260 128 110
Totale 4.813